These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3658068)

  • 1. Hypercalcemia and elevated 1,25(OH)2D3 levels in a dialysis patient with disseminated tuberculosis.
    Peces R; Alvarez J
    Nephron; 1987; 46(4):377-9. PubMed ID: 3658068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of hypercalcemia, elevated levels of calcitriol and tuberculosis in patients on hemodialysis].
    Peces R; Díaz Corte C
    Nefrologia; 2000; 20(5):448-54. PubMed ID: 11100667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia and elevated calcitriol in a maintenance dialysis patient with tuberculosis.
    Felsenfeld AJ; Drezner MK; Llach F
    Arch Intern Med; 1986 Oct; 146(10):1941-5. PubMed ID: 3767540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High ratio of 1,25-dihydroxyvitamin D3 to parathyroid hormone in serum of tuberculous patients with end-stage renal disease.
    Yonemura K; Ohtake T; Matsushima H; Fujigaki Y; Hishida A
    Clin Nephrol; 2004 Sep; 62(3):202-7. PubMed ID: 15481852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis and hypercalcemia].
    Santos JM; Monteiro P; Fortes A; Silva E; Barbosa MA; da Palma-Carlos AG
    Acta Med Port; 1996; 9(7-9):275-7. PubMed ID: 9005710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia, inappropriate calcitriol levels, and tuberculosis on hemodialysis.
    Peces R; Pobes A; Díaz-Corte C; Gago E
    Scand J Urol Nephrol; 2000 Aug; 34(4):287-8. PubMed ID: 11095092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia and elevated serum 1.25-dihydroxyvitamin D in an end-stage renal disease patient with pulmonary cryptococcosis.
    Wang IK; Shen TY; Lee KF; Chang HY; Lin CL; Chuang FR
    Ren Fail; 2004 May; 26(3):333-8. PubMed ID: 15354986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end-stage renal disease and active tuberculosis.
    Gkonos PJ; London R; Hendler ED
    N Engl J Med; 1984 Dec; 311(26):1683-5. PubMed ID: 6548798
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sarcoidosis and hypercalcemia in a patient undergoing hemodialysis].
    Kuwae N; Oshiro Y; Nakazato S
    Nihon Jinzo Gakkai Shi; 2003; 45(2):98-103. PubMed ID: 12703405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse calcinosis and intradermal tophi in a uremic pateint: effect of low-calcium hemodialysis and mechanism of hypercalcemia.
    Hsu SC; Lee YY; Wang MC; Liu HL; Cheng MF; Huang JJ
    Blood Purif; 2004; 22(2):224-8. PubMed ID: 15044822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia and elevated 1,25-(OH)2D levels in a patient with end-stage renal disease and active tuberculosis.
    Fuss M; Karmali R; Bergman P; Gillet C; Prigogine T; Schmerber J; Brauman H; Corvilain J; Dierckx P
    N Engl J Med; 1985 Jun; 312(23):1520-1. PubMed ID: 3838800
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe hypercalcaemia with normal serum calcitriol in a diabetic patient with chronic renal failure, autoimmune hepatitis and disseminated tuberculosis.
    Yen TH; Huang JY; Wu CH; Lee KF; Huang CC
    Nephrol Dial Transplant; 2000 Dec; 15(12):2046-9. PubMed ID: 11096153
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis.
    Bell NH; Shary J; Shaw S; Turner RT
    Calcif Tissue Int; 1985 Dec; 37(6):588-91. PubMed ID: 3937578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
    Coen G; Mazzaferro S; Bonucci E; Ballanti P; Massimetti C; Donato G; Landi A; Smacchi A; Della Rocca C; Cinotti GA
    Miner Electrolyte Metab; 1986; 12(5-6):375-82. PubMed ID: 3492662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism.
    Tsukamoto Y; Nomura M; Takahashi Y; Takagi Y; Yoshida A; Nagaoka T; Togashi K; Kikawada R; Marumo F
    Nephron; 1991; 57(1):23-8. PubMed ID: 2046811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumoral calcinosis associated with hypercalcemia in a patient with chronic renal failure.
    Horikoshi R; Akimoto T; Meguro D; Saito O; Ando Y; Muto S; Kusano E
    Clin Exp Nephrol; 2011 Feb; 15(1):154-8. PubMed ID: 20972694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review.
    Kallas M; Green F; Hewison M; White C; Kline G
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3111-7. PubMed ID: 20427501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid effect of prednisolone on serum 1,25-dihydroxycholecalciferol levels in hypercalcemic sarcoidosis.
    Nordal KP; Dahl E; Halse J; Aksnes L; Aarskog D
    Acta Med Scand; 1985; 218(5):519-23. PubMed ID: 3841460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.